Research guide

TB-500

Thymosin beta-4 fragment

A commercial research label associated with thymosin beta-4-related products.

Compare
Product statusUnapproved / RUO
Development snapshotRUO

How it works, simply

The proposed repair rationale comes from pathways involved in cell movement and tissue responses.

What the evidence tells us

TB-500 and full-length thymosin beta-4 must not be assumed identical. A seller's label does not prove molecular identity or human benefit.

Watch with PEP 7

A short introduction; the sources and limitations remain important.

Open video guide

Video guides are coming soon.

Risks and open questions

This guide does not establish a safe dose, interaction profile or long-term safety for self-use. Effects reported for one route or formulation may not apply to another.

Research and education only. PepGuide does not recommend medicines, doses or protocols.

Technical details and study context

Mechanism: Marketed wound-healing and recovery mechanisms are not established as human clinical efficacy.

Sponsor or developer: No approved-product sponsor

Studied or labeled topics: Recovery claims, Wound-healing claims

Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.

Sources and review dates

Product labels and further research

These directories help locate records. They are not individual studies supporting every statement.

Readability updated October 10, 2026. Evidence review: October 10, 2026 (FDA safety context only). A wording update is not a new clinical review.